Jazz Pharmaceuticals plc (JAZZ) Form 4 Filed by Renee D Gala, Jul 02, 2026

SEC Form 4 · No Market Transaction
Tax Withholding

Shares withheld for tax obligations.

Reporting Owner
TXN 2026-06-30 · FILED 2026-07-02
Equity Position 147K sh 152,196 → 147,361
Equity Change -3.2% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-07-02
Report Date
2026-07-02
Accession No.
0001607737-26-000011
Accepted At
2026-07-02 22:21 UTC
Reporting Owner
Name Relationship
Renee D Gala CIK 0001607737
CEO
Renee D Gala at Jazz Pharmaceuticals plc Full insider history
Bought (12 mo) —
Sold (12 mo) $1,184,230
More from this insider at Jazz Pharmaceuticals plc
2026-11-05 Sell -$225,370 View
2026-10-07 Sell -$472,800 View
2026-09-10 Sell -$486,060 View
2026-06-05 Gift/Other — View
2026-03-09 - — View
All filings by this insider at Jazz Pharmaceuticals plc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Ordinary SharesF1 2026-06-30 F - Tax Payment 4,835 D $237.72 -$1,149,376 147,361 Direct
Footnotes (1)
F1
Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Show more
5%+ Holders · 13D/G 2 filers
Other insiders at Jazz Pharmaceuticals plc
All Jazz Pharmaceuticals plc insider activity
GET /v1/forms/4/0001607737-26-000011 API docs
View Original SEC Filing